Belgium said on Wednesday it was suspending vaccinations with Johnson & Johnson’s Janssen COVID-19 vaccine for people under the age of 41 following the death of a woman from severe side effects after she was given the shot. “The Inter-ministerial conference has decided to temporarily administer Janssen’s vaccine to the general population from the age of 41 years, pending a more detailed benefit-risk analysis by the EMA,” said a statement issued by Belgium’s federal health minister and seven regional counterparts. EMA is the European Union’s European Medicines Agency. There was no immediate comment from EMA or J&J. The woman—who was under the age of 40—died on May 21 after being admitted to hospital with severe thrombosis and platelet deficiency, the statement said. She was vaccinated through her employer, outside of the official Belgian vaccination campaign. Belgium has so far administered about 40,000 J&J shots, with 80 percent of those to …